2016

1. Anti-HER2 Therapy beyond Second-Line for HER2- Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel

   Breast Care, Vol. 11, Núm. 2, pp. 133-138